BBH Holdings Information

BBH is an equity ETF with a total of 26 individual holdings. The top holdings are Amgen stock at 12.84%, Gilead Sciences at 11.84%, Vertex Pharmaceuticals at 9.24%, Regeneron Pharmaceuticals at 5.09%, and argenx SE at 4.95%.

Total Holdings

Top 10 Percentage

66.46%

Asset Class

Equity

ETF Category

Health

Assets

352.73M

PE Ratio

18.81

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	12.84%	152,065
2	GILD	Gilead Sciences, Inc.	11.84%	370,791
3	VRTX	Vertex Pharmaceuticals Incorporated	9.24%	80,814
4	REGN	Regeneron Pharmaceuticals, Inc.	5.09%	29,935
5	ARGX	argenx SE	4.95%	21,814
6	IQV	IQVIA Holdings Inc.	4.77%	81,453
7	ALNY	Alnylam Pharmaceuticals, Inc.	4.59%	35,457
8	INSM	Insmed Incorporated	4.57%	102,630
9	ONC	BeOne Medicines AG	4.48%	45,960
10	NTRA	Natera, Inc.	4.10%	86,333
11	UTHR	United Therapeutics Corporation	3.65%	28,449
12	BIIB	Biogen Inc.	3.60%	79,413
13	ICLR	ICON Public Limited Company	3.55%	64,548
14	ILMN	Illumina, Inc.	2.57%	88,619
15	BNTX	BioNTech SE	2.42%	80,995
16	NBIX	Neurocrine Biosciences, Inc.	2.36%	60,652
17	INCY	Incyte Corporation	2.18%	88,712
18	TEM	Tempus AI, Inc.	2.07%	79,576
19	MRNA	Moderna, Inc.	1.92%	237,940
20	QGEN	Qiagen N.V.	1.79%	135,023
21	TECH	Bio-Techne Corporation	1.75%	97,845
22	BMRN	BioMarin Pharmaceutical Inc.	1.45%	92,259
23	CRL	Charles River Laboratories International, Inc.	1.43%	28,375
24	EXAS	Exact Sciences Corporation	1.41%	87,658
25	RGEN	Repligen Corporation	1.35%	31,950

Showing 25 of 26 holdings

Subscribe to see the full list

Activate Now

As of Oct 4, 2025